W. W. Solinge

发表

Partial pyruvate kinase deficiency aggravates the phenotypic expression of band 3 deficiency in a family with hereditary spherocytosis

G. Streekstra, J. Dobbe, R. Schutgens, 2015, American journal of hematology.

The effect of a preoperative erythropoietin protocol as part of a multifaceted blood management program in daily clinical practice (CME)

C. Kalkman, W. W. Solinge, H. J. Doodeman, 2013, Transfusion.

Validity of diagnostic codes and laboratory measurements to identify patients with idiopathic acute liver injury in a hospital database

T. Egberts, H. Leufkens, M. D. De Bruin, 2016, Pharmacoepidemiology and drug safety.

Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: A systematic review

T. Egberts, P. Jansen, R. Marum, 2013, Ageing Research Reviews.

Database koppelt gegevens laboratorium en apotheek

A. Egberts, A. Huisman, W. W. Solinge, 2005 .

Occurrence and determinants of poor response to short‐term pre‐operative erythropoietin treatment

A. Egberts, C. Kalkman, W. W. Solinge, 2013, Acta anaesthesiologica Scandinavica.

Expression but Incomplete Colorectal Carcinomas Maturation of Progastrin in

J. Rehfeld, F. Nielsen, W. W. Solinge, 1993 .

Enzymes of the Red Blood Cell

W. W. Solinge, R. Wijk, 2012 .

GATA-1 binding sites in exon 1 direct erythroid-specific transcription of PPOX.

W. W. Solinge, R. Wijk, K. Vooght, 2008 .

Rituximab‐induced thrombocytopenia: a cohort study

T. Egberts, H. Leufkens, S. Straus, 2012, European journal of haematology.

In vivo–activated CD103 Tregs: of men and

A. Demir, W. W. Solinge, P. Vergouwen, 2009 .

Characterization of the − 16C>G sequence variation in the promoters of both HBG1 and HBG2: Convergent evolution of the human γ-globin genes

H. C. P. Amstel, W. W. Solinge, R. Wijk, 2007 .

Hypothermic cardiopulmonary bypass surgery in a 7-year-old boy with a cold agglutinin

K. D. de Vooght, W. W. Solinge, I. Hubeek, 2012, Annals of Hematology.

Molecular studies reveal a concordant KEL genotyping between patients with hemoglobinopathies and blood donors in São Paulo City, Brazil

W. W. Solinge, R. Wijk, A. V. Wesel, 2008 .

The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis

Richard van Wijk, Wouter W. van Solinge, W. W. Solinge, 2005 .

Ex vivo analysis of aberrant splicing induced by two donor site mutations in PKLR of a patient with severe pyruvate kinase deficiency

Adri A. M. Thomas, G. Rijksen, W. W. Solinge, 2004, British journal of haematology.

Serum Potassium Influencing Interacting Drugs: Risk-Modifying Strategies Also Needed at Discontinuation

T. Egberts, E. Uijtendaal, W. W. Solinge, 2012, The Annals of pharmacotherapy.

Management of gene promoter mutations in molecular diagnostics.

W. W. Solinge, R. Wijk, K. Vooght, 2009 .

Medication Changes Prior to Hospitalization for Obstructive Lung Disease: A Case-Crossover Study

P. Souverein, H. Leufkens, K. J. Velthove, 2010, The Annals of pharmacotherapy.

associated with type I factor V deficiency Five novel mutations in the gene for human blood coagulation factor V

E. Huizinga, R. Kraaijenhagen, W. W. Solinge, 2011 .

Express and Process Progastrin1

J. Rehfeld, W. W. Solinge, Lars Dum, 2006 .

Gene promoter analysis in molecular diagnostics: do or don't?

W. W. Solinge, K. Vooght, 2009 .

Characterization of the -148C>T promoter polymorphism in PKLR.

W. W. Solinge, R. Wijk, K. Vooght, 2008 .

Molecular characterisation of pyruvate kinase deficiency – concerns about the description of mutant PKLR alleles

G. Rijksen, W. W. Solinge, R. Wijk, 2007, British journal of haematology.

CHAPTER 4 Fourteen novel mutations in PKLR associated with pyruvate kinase deficiency

E. Huizinga, G. Rijksen, W. W. Solinge, 2004 .

Gastrin, cholecystokinin and their precursors in acoustic neuromas

J. Rehfeld, J. Thomsen, W. W. Solinge, 1990, Brain Research.

Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions

T. Egberts, A. Geerts, P. D. Smet, 2009, Drug safety.

long-distance runner Glucose 6-phosphate dehydrogenase deficiency in an elite

R. Schutgens, G. Rijksen, A. Demir, 2011 .

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency.

M. van den Berg, E. Huizinga, R. Kraaijenhagen, 2001, Blood.

Quantitative erythrocyte membrane proteome analysis with Blue-native/SDS PAGE.

Albert J R Heck, Wouter W van Solinge, A. Heck, 2010, Journal of proteomics.

Feasibility of point‐of‐care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients

A. Egberts, A. Geerts, P. D. Smet, 2013, Journal of clinical pharmacy and therapeutics.

Expression but incomplete maturation of progastrin in colorectal carcinomas.

J. Rehfeld, J. Rehfeld, F. Nielsen, 1993, Gastroenterology.

Feasibility of point‐of‐care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients

A. Egberts, A. Geerts, P. D. Smet, 2013, Journal of clinical pharmacy and therapeutics.

12 – Cell-Specific Expression and Processing of Procholecystokinin and Progastrin

J. Rehfeld, L. Bardram, L. Hilsted, 1990 .

Open Access METHODOLOGY

P. Souverein, H. Leufkens, K. J. Velthove, 2010 .

A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.

A. Hagenbeek, W. V. van Solinge, A. Buijs, 2001, Blood.

Quantitative erythrocyte membrane proteome analysis with Blue-native/SDS PAGE.

A. Heck, M. Slijper, G. Rijksen, 2010, Journal of proteomics.

Use of real-time quantitative PCR to compare DNA isolation methods.

D. Swinkels, J. Hendriks, H. Willems, 1998, Clinical chemistry.

Mutations in the human pyruvate kinase gene leading to pyruvate kinase deficiency, in the Netherlands.

E. Huizinga, G. Rijksen, W. W. Solinge, 2001 .

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency.

E. Huizinga, R. Kraaijenhagen, W. W. Solinge, 2001, Blood.

Molecular modelling of human red blood cell pyruvate kinase: structural implications of a novel G1091 to a mutation causing severe nonspherocytic hemolytic anemia.

M. Gajhede, F. Nielsen, R. Kraaijenhagen, 1997, Blood.